QUADRANT CAPITAL GROUP LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$4,312
+13.6%
400.0%0.00%
Q1 2024$3,795
-33.6%
40
-35.5%
0.00%
Q4 2023$5,719
+3687.4%
62
+1966.7%
0.00%
Q3 2023$151
-98.3%
3
-97.9%
0.00%
-100.0%
Q2 2023$8,975
+6548.1%
142
+4633.3%
0.00%
Q1 2023$135
-89.7%
3
-90.0%
0.00%
Q4 2022$1,314
+31.4%
30
+42.9%
0.00%
Q3 2022$1,000
-66.7%
21
-69.6%
0.00%
Q2 2022$3,000
+200.0%
69
+666.7%
0.00%
Q1 2022$1,0000.0%9
-35.7%
0.00%
Q4 2021$1,000
-75.0%
14
-65.0%
0.00%
-100.0%
Q3 2021$4,000
+300.0%
40
+344.4%
0.00%
Q2 2021$1,000
-50.0%
9
-64.0%
0.00%
Q1 2021$2,00025
+525.0%
0.00%
Q4 2020$040.0%0.00%
Q3 2020$040.0%0.00%
Q2 2020$0
-100.0%
4
-99.6%
0.00%
-100.0%
Q1 2020$56,000
+600.0%
969
+822.9%
0.01%
+800.0%
Q4 2019$8,000
-69.2%
105
-70.8%
0.00%
-75.0%
Q3 2019$26,000
-21.2%
3590.0%0.00%
-20.0%
Q2 2019$33,0003590.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders